Beam Therapeutics Inc.
BEAMFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
64
Cost of Revenue
22
Gross Profit
42
Gross Margin
65.5%
Operating Income
-416
Operating Margin
-654.3%
Net Income
-377
Net Margin
-593.1%
EPS (Basic)
$-4.58
EPS (Diluted)
$-4.58
EBITDA
-384
EBITDA Margin
-604.5%
2023
12/31/2023
Revenue
378
Cost of Revenue
437
Gross Profit
-60
Gross Margin
-15.8%
Operating Income
-176
Operating Margin
-46.7%
Net Income
-133
Net Margin
-35.1%
EPS (Basic)
$-1.72
EPS (Diluted)
$-1.72
EBITDA
-156
EBITDA Margin
-41.4%
2022
12/31/2022
Revenue
61
Cost of Revenue
23
Gross Profit
38
Gross Margin
62.9%
Operating Income
-338
Operating Margin
-555.6%
Net Income
-264
Net Margin
-432.7%
EPS (Basic)
$-3.76
EPS (Diluted)
$-3.76
EBITDA
-324
EBITDA Margin
-532.4%
2021
12/31/2021
Revenue
52
Cost of Revenue
16
Gross Profit
35
Gross Margin
68.3%
Operating Income
-392
Operating Margin
-757.0%
Net Income
-341
Net Margin
-658.4%
EPS (Basic)
$-5.31
EPS (Diluted)
$-5.31
EBITDA
-392
EBITDA Margin
-757.0%
2020
12/31/2020
Revenue
0
Cost of Revenue
103
Gross Profit
-103
Gross Margin
-429812.5%
Operating Income
-133
Operating Margin
-553166.7%
Net Income
-256
Net Margin
-1068433.3%
EPS (Basic)
$-5.49
EPS (Diluted)
$-5.49
EBITDA
-128
EBITDA Margin
-533437.5%